Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use. Especially missed or delayed diagnosis of PC patients with negative CA19-9 value...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Zhong, Ailing, Qin, Ruihuan, Qin, Wenjun, Han, Jing, Gu, Yong, Zhou, Lei, Zhang, Hongqin, Ren, Shifang, Lu, Renquan, Guo, Lin, Gu, Jianxin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402387/
https://ncbi.nlm.nih.gov/pubmed/30873386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00114
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge